Thyrocare Technologies Ltd.
Snapshot View

419.45 -5.05 ▼-1.2%

28 March 2023, 04:01:00 PM
Volume: 4,370

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.thyrocare.com
Market Cap 2,219.89 Cr.
Enterprise Value(EV) 2,201.42 Cr. 2022-12
Financial Indicators
Earnings per share (EPS) 13.81 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 30.36 Trailing Twelve Months Ending 2022-12
Industry PE 45.91 Trailing Twelve Months Ending 2022-12
Book Value / Share 97.06 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.32 Calculated using Price: 419.45
Dividend Yield 3.58 Period Ending 2022-03
No. of Shares Subscribed 5.29 Cr. 52,930,043 Shares
FaceValue 10
Company Profile
Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.19%
1 Week
-7.82%
1 Month
-7.12%
3 Month
-31.95%
6 Month
-38.84%
1 Year
-45.87%
2 Year
-51.64%
5 Year
-30.23%
10 Year
8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.98 16.22 11.20 22.16 19.41 22.13 28.75 37.18
Return on Capital Employed (%) 24.57 25.66 21.05 33.93 31.36 35.14 38.51 48.24
Return on Assets (%) 13.41 14.09 10.20 20.59 17.93 18.73 22.43 30.87

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12* Rs. Cr.
Shh. Funds 276 366 408 443 435 367 427 527 514
Non Curr. Liab. 9 10 9 10 14 21 18 10 6
Curr. Liab. 7 31 18 20 21 82 95 65 71
Minority Int. 36 1
Equity & Liab. 328 407 434 474 470 469 540 601 591
Non Curr. Assets 218 273 285 332 334 317 300 331 345
Curr. Assets 111 134 150 142 136 152 240 270 246
Misc. Exp. not W/O
Total Assets 328 407 434 474 470 469 540 601 591

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 183 241 304 356 403 434 495 589 521
Other Income 8 7 12 23 10 7 12 29 7
Total Income 191 248 317 380 413 441 507 618 528
Total Expenditure -110 -147 -189 -212 -249 -261 -323 -354 -388
PBIDT 81 101 128 168 164 180 184 264 140
Interest 0 -1 0 0 -1 -2 -1 -2 -2
Depreciation -13 -18 -18 -20 -26 -32 -30 -34 -38
Taxation -24 -30 -39 -52 -53 -52 -39 -52 -28
Exceptional Items -27 -2 -7
PAT 44 52 43 93 85 88 113 176 72
Minority Interest 1 0
Share Associate 1 1 1
Other Related Items 0 -1 0
Consolidated Net Profit 45 52 43 93 85 89 112 176 73
Adjusted EPS 9 10 8 17 16 17 21 33 14

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 68 90 107 100 168 115 113
Cash Fr. Inv. -18 -18 -42 -43 -12 1 -49 -24
Cash Fr. Finan. -23 -45 -49 -64 -94 -165 -62 -89
Net Change -6 5 0 0 -5 4 4 0
Cash & Cash Eqvt 5 10 10 10 5 9 13 14

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 66.14 66.14 66.14 71.22 71.18 71.18 71.18 71.14 71.14
Public 33.86 33.86 33.86 28.78 28.82 28.82 28.82 28.86 28.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 100.00 100.00 100.00 100.00 100.00 100.00

Announcements View Details >>

Mon, 13 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Meeting with Investors/Analysts
Fri, 10 Mar 2023
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on March 10 2023 for Docon Technologies Pvt Ltd & API Holdings Ltd
Fri, 10 Mar 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 10 2023 for Docon Technologies Pvt Ltd & API Holdings Ltd

Technical Scans View Details >>

Tue, 28 Mar 2023
Close Crossing 52 Week Low Close Crossing 52 Week Low
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,534.70 +1.1%
Divi's Laboratories Ltd. 74,473.23 2,805.35 -0.8%
Cipla Ltd. 71,800.08 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,539.00 +0.3%
Zydus Lifesciences Ltd. 49,031.17 484.40 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-12 27.21 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 484.40 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-12 3.16 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 484.40 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 484.40 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 484.40 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 484.40 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 484.40 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 484.40 +0.4%

FAQ's On Thyrocare Technologies Ltd.

What is Thyrocare Tech. share price?

Can I buy Thyrocare Tech. shares now?

What is the Dividend Yield of Thyrocare Tech.?

What is the Market Cap of Thyrocare Tech.?

What are the key metrics to analyse Thyrocare Tech.?

What is the 52 Week High and Low of Thyrocare Tech.?

What is the trend of Thyrocare Tech. share price?